La jonction neuromusculaire revisitée

Nguyen-Cao, 2019, Myasthenia gravis: historical achievements and the “golden age” of clinical trials, J Neurol Sci, 406, 116428, 10.1016/j.jns.2019.116428 Gilhus, 2015, Myasthenia gravis: subgroup classification and therapeutic strategies, Lancet Neurol, 14, 1023, 10.1016/S1474-4422(15)00145-3 Mantegazza, 2018, Myasthenia gravis: from autoantibodies to therapy, Curr Opin Neurol, 31, 517, 10.1097/WCO.0000000000000596 Koneczny, 2019, Myasthenia gravis: pathogenic effects of autoantibodies on neuromuscular architecture, Cells, 8, 10.3390/cells8070671 Behin, 2018, New pathways and therapeutic targets in autoimmune myasthenia gravis, J Neuromuscul Dis, 5, 265, 10.3233/JND-170294 Souto, 2019, Myasthenia gravis: state of the art and new therapeutic strategies, J Neuroimmunol, 337, 577080, 10.1016/j.jneuroim.2019.577080 Gilhus, 2016, Myasthenia gravis - autoantibody characteristics and their implications for therapy, Nat Rev Neurol, 12, 259, 10.1038/nrneurol.2016.44 Catar, 2017, Myasthénie auto-immune séronégative, Med Sci (Paris), 33, 34, 10.1051/medsci/201733s107 Rivner, 2018, Muscle-specific tyrosine kinase and myasthenia gravis owing to other antibodies, Neurol Clin, 36, 293, 10.1016/j.ncl.2018.01.004 Morren, 2018, Myasthenia gravis with muscle-specific tyrosine kinase antibodies: a narrative review, Muscle Nerve, 58, 344, 10.1002/mus.26107 Yan, 2018, Agrin and LRP4 antibodies as new biomarkers of myasthenia gravis, Ann N Y Acad Sci, 1413, 126, 10.1111/nyas.13573 Pevzner, 2012, Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis, J Neurol, 259, 427, 10.1007/s00415-011-6194-7 Zisimopoulou, 2014, A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis, J Autoimmun, 52, 139, 10.1016/j.jaut.2013.12.004 Gasperi, 2014, Anti-agrin autoantibodies in myasthenia gravis, Neurology, 82, 1976, 10.1212/WNL.0000000000000478 Szczudlik, 2014, Antititin antibody in early- and late-onset myasthenia gravis, Acta Neurol Scand, 130, 229, 10.1111/ane.12271 Tsonis, 2015, MuSK autoantibodies in myasthenia gravis detected by cell based assay--A multinational study, J Neuroimmunol, 284, 10, 10.1016/j.jneuroim.2015.04.015 Hong, 2017, Multiple antibody detection in “seronegative” myasthenia gravis patients, Eur J Neurol, 24, 844, 10.1111/ene.13300 Binks, 2016, Myasthenia gravis: a clinical-immunological update, J Neurol, 263, 826, 10.1007/s00415-015-7963-5 Protocole National de Diagnostic et de Soins (PNDS), 2015 Wolfe, 2019, Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial, Lancet Neurol, 18, 259, 10.1016/S1474-4422(18)30392-2